People with neuromyelitis optica spectrum disorder (NMOSD) have significantly higher levels of chitotriosidase-1 (CHIT1), a protein involved in immune and…
Articles by Andrea Lobo
Ofatumumab, a medication approved for multiple sclerosis (MS), may effectively prevent relapses and disability in people with neuromyelitis optica…
People testing negative for self-reactive antibodies against aquaporin-4 (AQP4-IgGs) — the type of antibody most commonly linked to neuromyelitis…
Higher blood levels of the glial fibrillary acidic protein (GFAP) are significantly associated with shrinkage in certain brain regions of…
More than one-third of people with neuromyelitis optica spectrum disorder (NMOSD) have involuntary muscle contractions or movements, while about…
The activity of an immune-regulating protein is significantly lower just before or during a relapse in people with neuromyelitis…
Long-term use of the approved therapy Enspryng (satralizumab) safely and effectively prevented relapses in people with neuromyelitis optica…
Smoking is associated with a significantly higher risk of residual disability from onset attack in neuromyelitis optica spectrum disorder…
Switching from Soliris (eculizumab) to Enspryng (satralizumab) is a safe and effective approach for neuromyelitis optica spectrum…
Children with neuromyelitis optica spectrum disorder (NMOSD) who live in disadvantaged socioeconomic neighborhoods are more likely to have more…